Cervical Cancer Vaccine ‘Around the Corner’
A pioneering drug that could protect against cervical cancer could soon end the race to find a vaccine for the disease. The drug, which targets the virus that causes cancer of the cervix in women, could almost eradicate the disease, say researchers. In trials, the vaccine was also effective against genital warts, a sexually-transmitted infection affecting around two per cent of adults. Cervical cancer affects some 470,000 women a year and survival chances are good if the disease is detected and treated early.
The findings, published in the The Lancet Oncology, put pharmaceutical giants Merck & Co Inc ahead in the race to market the world’s first anti-cancer vaccine. It could be on the market in two years.